RETINALGENIX TECHNOLOGIES INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations
RETINALGENIX TECHNOLOGIES INC. (RTGN) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations of 12.50 thousand shares for the 12-month period ending 2022-12-31, per its 10-K/A filed 2023-06-15.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations · last filed 2023-06-15
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2022-12-31 was 0.00 shares.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for fiscal 2022 was 12.50K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 12 month |
|---|---|---|---|
| 2022-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-15 | 12.50K shares 10-K/A · filed 2023-06-15 | |
| 2022-09-30 | 12.50K shares 10-Q · filed 2022-11-17 |